These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Comprehensive testing for thalassemia trait. Pearson HA; McPhedran P; O'Brien RT; Aspnes GT; McIntosh S; Guiliotis DK Ann N Y Acad Sci; 1974; 232(0):135-44. PubMed ID: 4528485 [No Abstract] [Full Text] [Related]
26. Diagnosis of haemoglobinopathies in West of Scotland. Bulloch C; Helenglass G; Lucie NP Scott Med J; 1982 Jan; 27(1):44-8. PubMed ID: 6175021 [No Abstract] [Full Text] [Related]
27. Heterogeneity of beta/alpha ratio in Italian beta-thalassaemia heterozygotes. Sampietro M; Cappellini MD; Taddei MT; Fiorelli G Haematologica; 1983; 68(6):703-11. PubMed ID: 6199264 [No Abstract] [Full Text] [Related]
28. Dominant β-thalassemia - a rare entity! Khera R; Singh T Indian J Pathol Microbiol; 2012; 55(3):422-3. PubMed ID: 23032855 [No Abstract] [Full Text] [Related]
29. Antenatal screening and prenatal diagnosis of thalassaemia. Hendy JG; Monagle PT; Bowden DK Med J Aust; 1999 Jun; 170(12):621, 623-4. PubMed ID: 10416439 [No Abstract] [Full Text] [Related]
31. Prenatal diagnosis of hemoglobinopathies in Ontario, Canada. Basran RK; Patterson M; Walker L; Nakamura LM; Eng B; Chui DH; Waye JS Ann N Y Acad Sci; 2005; 1054():507-10. PubMed ID: 16339708 [TBL] [Abstract][Full Text] [Related]
32. [On the occurrence of fetal hemoglobin in acquired blood diseases]. Stobbe H; Scholz R Schweiz Med Wochenschr; 1966 Sep; 96(38):1269-72. PubMed ID: 6011256 [No Abstract] [Full Text] [Related]
33. [Methods recommended by the International Committee for Standardization in Hematology for the determination of hemoglobin A2]. Villegas A; Alvarez-Sala JL; Espinós D Sangre (Barc); 1982; 27(2):251-7. PubMed ID: 7123441 [No Abstract] [Full Text] [Related]
34. Prevention and control of thalassemia at Saraburi Regional Hospital. Chareonkul P; Kraisin J J Med Assoc Thai; 2004 Jan; 87(1):8-15. PubMed ID: 14971529 [TBL] [Abstract][Full Text] [Related]
35. Molecular basis and hematologic characterization of deltabeta-thalassemia and hereditary persistence of fetal hemoglobin in Thailand. Panyasai S; Fucharoen S; Surapot S; Fucharoen G; Sanchaisuriya K Haematologica; 2004 Jul; 89(7):777-81. PubMed ID: 15257928 [TBL] [Abstract][Full Text] [Related]
36. A rare and unstable hemoglobin variant, Hb M Dothan β 25/26 (-GTG), detected by the anomalous cytogram on Sysmex XE-2100. Mongelli F; Barberio G; Ivaldi G Clin Chem Lab Med; 2016 Feb; 54(2):e31-3. PubMed ID: 26351950 [No Abstract] [Full Text] [Related]
38. The validation of an automated liquid chromatography system for the diagnosis of thalassemias and hemoglobinopathies. Sangkitporn S; Pung-amritt P; Sangkitporn SK; Sangnoi A; Tanphaichitr VS Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):862-8. PubMed ID: 12757240 [TBL] [Abstract][Full Text] [Related]
39. A thalassaemia syndrome resulting from the interaction of delta-beta, beta, and alpha thalassaemia genes. A case report. Sansone G; Sciarratta GV; Agosti-Vallerino FS Pathologica; 1980; 72(1021):715-21. PubMed ID: 6170037 [No Abstract] [Full Text] [Related]
40. [The microcythemia problem in the Marches. Initial experiences in Vallesina]. Carotti A; Oggioni C; Binci MC; Piva W; Paolinelli E; Sani S; Carotti A Minerva Med; 1983 Dec; 74(49-50):2915-20. PubMed ID: 6664584 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]